Pieter Gillard

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Sara Charleer, Christophe De Block, Liesbeth Van Huffel et al. · Diabetes Care · 2019 · 252 citations · Full text

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Chantal Mathieu, Paresh Dandona, Pieter Gillard et al. · Diabetes Care · 2018 · 245 citations

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

Daniel Jacobs‐Tulleneers‐Thevissen, Marie Chintinne, Z. Ling et al. · Diabetologia · 2013 · 226 citations · Full text

Regenerative Medicine, Tissue Engineering, Type 1 +11

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

Othmar Moser, Michael C. Riddell, Max L. Eckstein et al. · Diabetologia · 2020 · 196 citations · Full text

Metabolic Syndrome, Type 1, Physical Activity +9